Charles D Nichols

Charles D Nichols

Louisiana State University

H-index: 38

North America-United States

About Charles D Nichols

Charles D Nichols, With an exceptional h-index of 38 and a recent h-index of 30 (since 2020), a distinguished researcher at Louisiana State University, specializes in the field of serotonin.

His recent articles reflect a diverse array of research interests and contributions to the field:

Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression

The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents

Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic

Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders

Method of treatment for psilocybin or psilocin infusion

A single administration of psilocybin persistently rescues cognitive deficits caused by adolescent chronic restraint stress without long-term changes in synaptic protein gene …

Compositions and methods to reduce pathogenesis

Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion

Charles D Nichols Information

University

Position

a Health Sciences Center

Citations(all)

7304

Citations(since 2020)

3894

Cited By

4666

hIndex(all)

38

hIndex(since 2020)

30

i10Index(all)

52

i10Index(since 2020)

49

Email

University Profile Page

Louisiana State University

Google Scholar

View Google Scholar Profile

Charles D Nichols Skills & Research Interests

serotonin

Top articles of Charles D Nichols

Title

Journal

Author(s)

Publication Date

Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression

ACS Pharmacology & Translational Science

Thomas W Flanagan

Timothy P Foster

Thomas E Galbato

Pek Yee Lum

Brent Louie

...

2024/1/25

The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents

bioRxiv

Anders A Jensen

Claudia R Cecchi

Meghan Hibicke

Astrid H Bach

Erik Kaadt

...

2024

Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic

Psychedelic Medicine

Meghan Hibicke

Gerald Billac

Charles D Nichols

2024/2/27

Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders

Andreas B Wulff

Charles D Nichols

Scott M Thompson

2023/3/13

Method of treatment for psilocybin or psilocin infusion

2023/9/7

A single administration of psilocybin persistently rescues cognitive deficits caused by adolescent chronic restraint stress without long-term changes in synaptic protein gene …

Psychedelic Medicine

Meghan Hibicke

Hannah M Kramer

Charles D Nichols

2023/3/1

Compositions and methods to reduce pathogenesis

2023/9/7

Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion

Psychedelic Medicine

Peter S Hendricks

Charles D Nichols

Kathryn A Cunningham

Mark A Geyer

Roland Griffiths

...

2023/3/1

The Elephant in the Room: Personal Use of Psychedelics Among Psychedelic Researchers

Peter S Hendricks

Charles D Nichols

2023/9/1

5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?

Haley Maria Dourron

Charles D Nichols

Otto Simonsson

Melissa Bradley

Robin Carhart-Harris

...

2023/12/11

Proposed consensus statement on defining psychedelic drugs

Psychedelic Medicine

David E Nichols

Charles D Nichols

Peter S Hendricks

2023/3/1

Psychedelic commercialization: A wide-spanning overview of the emerging psychedelic industry

Jacob S Aday

Brian S Barnett

Dan Grossman

Kevin S Murnane

Charles D Nichols

...

2023/9/1

If Everything Is Psychedelic, Then Nothing Is: A Response to O'Donnell et al. and Lepow et al.

Psychedelic Medicine

David E Nichols

Peter S Hendricks

Charles D Nichols

2023/12/1

Editors' Introduction to Psychedelic Medicine

Peter S Hendricks

Charles D Nichols

2023/3/1

Conditioned place avoidance is associated with a distinct hippocampal phenotype, partly preserved pattern separation, and reduced reactive oxygen species production after stress

Genes, Brain and Behavior

D Parker Kelley

Lucas Albrechet‐Souza

Shealan Cruise

Rajani Maiya

Aspasia Destouni

...

2023/4

Compositions and methods for treating ocular pathologies

2023/9/19

Herpes Simplex Virus-1 Induced Serotonin-Associated Metabolic Pathways Correlate With Severity of Virus-and Inflammation-Associated Ocular Disease

Frontiers in Microbiology

Diana Marie Battaglia

Maria D Sanchez-Pino

Charles D Nichols

Timothy P Foster

2022/3/22

Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies

Scientific Reports

M Hibicke

CD Nichols

2022/6/15

Psychedelics as potent anti-inflammatory therapeutics

Charles D Nichols

2022/11/15

Pharmahuasca and DMT rescue ROS production and differentially expressed genes observed after predator and psychosocial stress: relevance to human PTSD

ACS chemical neuroscience

D Parker Kelley

Katy Venable

Aspasia Destouni

Gerald Billac

Philip Ebenezer

...

2022/1/6

See List of Professors in Charles D Nichols University(Louisiana State University)